Welcome to Predictmedix
We develop disruptive AI technologies for
health and safety in workplaces and healthcare.
“We wanted the best possible solution available on the market. Safe Entry was far superior to any other solutions we explored, and I can honestly say it lived up to all the hype and more. Identifying symptomatic individuals allowed us to keep the rest of our guests safe so that they could enjoy the festivities.”
-Michael Piper, Principal, Pied Piper Productions
Introducing Safe Entry
AI powered, Infectious Disease Symptom Screening Solution to keep your staff, guests, and customers safe.
- Quick, non-invasive, contactless screening
- Fully automated without the need for personnel to operate
- Indicates positive or negative result so safety protocols can be initiated
Disruptive technologies for a better, safer world.
Infectious Disease Symptom Screening
Infections including COVID-19, produce unique physiological patterns that our solution will detect, assess and determine the probability of that person being infected or not infected.
As the virus mutates, our AI will learn how new symptoms present new patterns from which to continue detecting infection.
Our Infectious Disease Symptom Screening Solution is critical even after an effective, safe vaccine has successfully been deployed to at least 80% of the global population in the coming years as annual flu and other infectious diseases proliferate.
Cannabis & Alcohol Screening
Employers, as well as law enforcement, test people for traces of cannabis, alcohol and opioids. However, they cannot determine if individuals are actually impaired.
Without the ability to determine impairment, it is not possible to accurately predict safety risk, particularly for cannabis which is now medically prescribed and also legal for recreational use in many provinces and states.
Our Cannabis & Alcohol Screening technology tests for impairment using multispectral recognition technologies that capture data patterns that are instantly analyzed by our proprietary AI.
Mental Illness Diagnostic Screening (Beta)
Mental illness is difficult to detect at early stages. Primarily due to a lack of diagnostic tools other than standardized surveys and subjective assessment from trained healthcare practitioners.
Using multispectral image patterns, we will be able to effectively determine signs of mental illnesses, including depression, dementia, and Alzheimer’s.
Mobile Wellbeing. Next Gen Virtual Care
Our Remote Patient Monitoring & Telehealth platform for long-term care and retirement residences, clinical research organizations, and large-scale employers.
Powered by Artificial Intelligence.
Our screening solutions are powered by AI. We use multispectral cameras and sensors that capture data patterns that are instantly analyzed by our proprietary AI. Our AI models continuously evolve via Machine Learning to keep you safe. That is the power of AI.
Industries we are serving
Our diverse partnerships allow us to serve industries that need our solutions most.
Rapid Mass Infection Screening, Mental Diagnostic Screening, and Remote Patient Care are tools we are excited to be bringing to the Healthcare sector.
Our Safe Entry Stations protect your employees and customers. Having non-invasive, contactless and fully automated screening is paramount when it comes to COVID-proofing your business, keeping everyone safe, and building trust with your clients and customers.
Industries like Oil & Gas, Construction, Manufacturing, Mining, etc. are in need of impairment detection technology that can accurately test for actual impairment from alcohol, cannabis and opioids not just traces of these substances in the body.
Employers, as well as law enforcement, test people for traces of cannabis, alcohol and opioids. However, they cannot determine if individuals are actually impaired. We are solving that problem with our Cannabis & Alcohol Impairment Screening Solutions.
Our Strategic Partnerships
Recent Company Updates
Toronto, ON / June 18, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), announced today that it has filed a registration statement on Form 20-F to register its common shares with the United States Securities and Exchange...
Predictmedix Announces Partnership with SBL Testing Technologies for Distribution of Safe Entry Stations
Toronto, ON / June 11, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), is pleased to announce expansion of their Safe Entry program with the institution of their first distributor, SBL Testing Technologies Inc (SBL) in partnership...
Toronto, ON / June 3, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), is pleased to announce the deployment of Safe Entry Stations at the Lavazza Drive In Film Festival to be held in Ontario from June 27 to July 17. ...